COVID-19 Molecular test updates

QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions

C-reactive protein testing: Powering precision in inflammation and cardiovascular diagnostics

Fujirebio receives FDA marketing clearance for first Alzheimer's blood test

Roche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-small cell lung cancer patients eligible for treatment with EMRELIS

Breast cancer biomarker uncovered